Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“This study clearly shows that curcumin nanoparticles could deliver DOX efficiently…Surprisingly, extracellular alkalization induced a 2- to 3-fold increase in the efficacy of doxorubicin…” Before
Continue readingHeart failure (HF) is an increasingly prevalent health problem affecting more than 15 million of patients worldwide.1… it still has a poor prognosis.2, 3 Only 35% of patients will survive within
Continue readingSurvivors of breast cancer, prostate cancer, and childhood leukemia are at particularly high risk for changes in bone mineral density (BMD) / osteoporosis that can lead to fractures. In breast and prostate
Continue reading“Patients with myeloid malignancies who have vitamin D deficiency prior to allogeneic stem cell transplantation (alloSCT) have an increased risk of relapse It is standard therapy for newly diagnosed
Continue reading“Thus, it seems that Velcade (bortezomib) is able to significantly overcome the poor prognosis of t(4;14) …Curcumin and bortezomib could exert synergistic effects on Multiple Myeloma cells,
Continue readingThe leading cause of legal blindness, age-related macular degeneration affects more than 10 million Americans — more than cataracts and glaucoma combined Aggressive, high-dose chemotherapy and radiation
Continue readingResearch Cites both Curcumin and Omega-3 Fatty Acids as effective in patients with diagnosis of MDD and on depressive patients without diagnosis of MDD” For a long time I was a multiple myeloma
Continue reading“The present study shows that the Lactobacillus rhamnosus CGMCC1.3724 formulation helps obese women to achieve sustainable weight loss.” Multiple myeloma survival is about more than remissions
Continue readingUnfortunately, the (clinical trials) program is bloated, cumbersome, inefficient, slow-paced, overmanaged, and expensive. Layers of bureaucracy at participating institutions… I am a survivor of an
Continue reading“Tumors need a blood supply to grow so they require new blood vessels. The native blood supply is insufficient, so angiogenesis is stimulated by the cancer itself for its own growth.” The article
Continue readingWhile the first (contrast agent for MRI) was approved by the U.S. Food and Drug Administration (FDA) in 1988, there are lingering safety concerns about these agents (especially for MM)… Multiple
Continue reading“We postulate that strategies aimed at prevention have the potential to be more effective in preventing myeloma-related death than additional pharmaceutical strategies aimed at treating advanced
Continue reading